Substitute while the actions of the article are loading
Democrat leaders have finalized a revised proposal to lower the prices of prescription drugs for the elderly, part of a broader struggle to satisfy Senator Joe Manchin (DW.Va.) and resurrect a long-stalled economic package they hope to move further this summer.
The development follows weeks of much private conversation between Senate Majority Leader Charles E. Schumer (DN.Y.) and Manchin, a centrist whose cost concerns thwarted an earlier bill known as the Back Building Better. This has positioned Democrats to launch a key part of the legislative process around their agenda, even as they argue with the West Virginia MP over other plans to cut health care spending and combat climate change.
Democrats are vying to revive the economic package as inflation soars
The revised pricing proposal for prescription drugs is very similar to the plan Democrats unveiled last year, according to three people familiar with the matter, who spoke on condition of anonymity to describe the discussions. In general, it entitles the US government to negotiate the price of selected drugs on behalf of Medicare beneficiaries, which Democrats say will reduce costs in the coming years.
According to the proposal, drug talks should begin in 2023, according to details received from The Washington Post. Democrats have also kept plans to cut the cost of Medicare drugs to the elderly to $ 2,000 each year, while punishing companies that raise prescription prices faster than inflation.
For the first time, however, Democrats have recently sought to close what they see as a loophole that may have allowed future administrations to refrain from aggressive negotiations, according to documents. The move is intended to ensure that the government still seeks to keep drug prices down, even if control of Washington changes, as Republicans have long opposed these negotiating powers, said one person familiar with the matter. Democrats also plan to expand additional support to a wider range of low-income seniors, hoping to help them afford their bonuses and co-payments.
Manchin publicly backed his party’s latest attempt to cut drug prices for the elderly. Since then, he has repeatedly said he remains committed to the idea, especially as spending across the economy rises. However, despite his comments, other Democrats remain uneasy about his preferences – a reflection of the tumultuous, changing and extensive talks between moderate West Virginia and members of his own party.
Democrats still hope to adopt the drug pricing plan as part of a larger economic package that will continue through the narrowly divided Senate, using the process known as reconciliation. The move allows the party to bypass the Republican filibuster – but only if every Democrat, including Manchin, unites with the help of a decisive vote by Vice President Harris.
In private, Sumer told members of his assembly that a quick decision would allow them to submit a new bill in late July, one source said. To achieve this goal, Democrats plan to present their new drug pricing proposal to the Senate MP this week, sources said. This seemingly bureaucratic step has huge consequences: the chief guardian of the chamber’s rules has great power in determining whether MPs’ plans comply with strict conciliation rules, which limits legislation to proposals that have a direct budgetary impact.
The process is long and complicated, and if the drug pricing proposal does not fall within the guardrail, this could lead to its complete exclusion from the Democrats’ final measure. Similar concerns loomed over the party’s attempts to deal with drug spending last year, especially their proposals to limit the price of insulin, whose fate remains unclear as bipartisan talks continue.
Manchin, a spokesman for Manchin, said in a statement that the senator “has long advocated proposals that would reduce the cost of prescription drugs for the elderly and his support for the proposal has never been questioned. that all 50 Democrats agree. “
A Sumerian spokesman declined to comment, citing Democrat leader comments last week that the two had “very good and productive discussions”, although “there are still some issues that need to be resolved”.
The renewed efforts among Democrats to revive their agenda reflect the political and economic urgency of the moment. For more than a year, party lawmakers have struggled to deliver on promises made during the last election, including promises to cut drug spending. But they have largely failed to do so, blocked by one of their own members, an opposition many Democrats fear could cost them control of Congress in November.
How the White House lost Joe Manchin – and his plan to transform America
Manchin maintains resistance to spending as much as the Democrats originally wanted in their proposal, known as the Better Law Restoration Act, which was once valued at approximately $ 2 trillion. He argues that such spending could lead to an increase in debt and worsen inflation when spending is already rising sharply. The senator’s position has put him at odds with others in his party, who say their initial bill was fully paid with new federal revenue and may have helped families cope with their biggest sources of financial stress.
Yet Democrats cannot continue without Manchin’s vote, a reality that has already forced them to sacrifice some of their most valuable proposals – including those for free kindergartens, cutting childcare costs, offering more cheap care for the elderly, allowing a nationally paid family and medical leave and invest a lot in housing. They are now exploring a far smaller package that focuses largely on reducing the cost of medicines, investing in green energy and making some changes to the tax code that could help reduce the deficit.
Many of these areas remain unresolved in the Manchin-Sumer talks, including a plan to expand subsidies for millions of Americans who buy health insurance through national exchanges originally created by the Affordable Care Act, sources said. Without a resolution, more than 13 million people could see an increase in premiums next year.
With drug pricing, Democrats have settled again to provide access to all free adult vaccines at Medicare, which currently do not have such benefits, according to plan details reviewed by The Post. It further expands premium benefits and co-payments to a larger proportion of low-income older Americans. And the initiative aims to encourage investment in generic drugs, which could further save the elderly, sources said.
Democrats, meanwhile, have tried to work with Republicans on a separate, stand-alone measure to provide financial relief to people with diabetes. This spring, the House of Representatives passed a bill to limit insulin spending, and Senators Jeanne Shaheen (DN.H.) and Susan Collins (R-Maine) published their own proposal this month, making further revisions to the system. Sumer promised to put it to a vote, although it remains unclear whether he can win the support of at least 10 Republicans in the Senate to avoid fraud.
Rachel Reuben contributed to this report.
Add Comment